Clinical TrialsSearch results
Number of results: 2568
Recruiting
- Study of safety and efficacy of KFA115 alone or in combination with tislelizumab in patients with select advanced cancers
- Advanced or metastatic disease
- Yonemura Masataka
- 2023-10-17
Other
- Drug-drug interactions study of TAS-115 in patients with solid tumors
- Advanced or metastatic solid tumor
- Motoo Yoshiharu
- 2021-10-11
Other
- A Study of TAK-981 Given With Pembrolizumab in Participants With Select Advanced or Metastatic Solid Tumors
- Advanced or Metastatic Solid Tumors
- Nakayama Ippei
- 2021-11-09
Recruiting
- ONO-7914-01:Phase I study of ONO-7914 alone and in combination with ONO-4538 in patients with solid tumors
- advanced or metastatic solid tumors
- Hirashima Yoshinori
- 2021-12-28
Recruiting
- ONO-4538HSC-01:A phase I study of ONO-4538HSC in subjects with advanced or metastatic solid tumors
- Advanced or metastatic solid tumors
- Hirashima Yoshinori
- 2024-03-05
Recruiting
- A Phase I/IIa Open-label Dose Escalation and Expansion Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of AZD7789, an Anti-PD-1 and Anti-TIM-3 Bispecific Antibody, in Participants With Advanced or Metastatic Solid Tumors.
- Advanced or Metastatic Solid Tumors
- Hibi Kazushige
- 2023-03-02
Other
- Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of D-1553 in Subjects with Advanced or Metastatic Solid Tumors
- Advanced or metastatic solid tumors with KRASG12C mutations
- Kitano Tina
- 2022-04-08
Not yet recruiting
- Rollover study of a prior clinical trial for patients with a judged favourable benefit/risk ratio for continued treatment with D-1553.
- Advanced or metastatic solid tumors with KRASG12C mutations
- Kitano Tina
- 2024-02-15
Recruiting
- A Phase I clinical study of KK2260 in patients with advanced or metastatic solid tumors
- Advanced or metastatic solid tumors, esophageal cancer, head and neck squamous cell carcinoma
- Takase Riho
- 2023-09-27
Other
- A phase II randomized study of DP(Docetaxel+Cisplatin),DJ(Docetaxel+Carboplatin),and TJ(Paclitaxel+Carboplatin) in patients with advanced and recurrent endometrial carcinoma
- advanced or recurrent endometrial carcinoma
- Japanese Gynecologic Oncology Group
- 2005-09-15